Garbiñe Roy Selected Research

Docosahexaenoic Acids

11/2020

Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Garbiñe Roy Research Topics

Disease

2	Rheumatoid Arthritis 01/2021 - 01/2020
2	Atrophy 01/2020 - 08/2004
1	Ulcerative Colitis 01/2021
1	Clostridium Infections 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 11/2020
1	Inflammation (Inflammations) 11/2020
1	Lymphoma (Lymphomas) 05/2008
1	Celiac Disease (Celiac Sprue) 03/2005
1	Smallpox (Variola) 11/2004
1	Autoimmune enteropathy 08/2004
1	Diarrhea 08/2004

Drug/Important Bio-Agent (IBA)

2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Docosahexaenoic AcidsIBA 11/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	SteroidsIBA 05/2008
1	CytokinesIBA 03/2005
1	VaccinesIBA 11/2004
1	AutoantibodiesIBA 08/2004

Therapy/Procedure

1	Biological Therapy 01/2021
1	Fecal Microbiota Transplantation 01/2021
1	Donor Selection 01/2021
1	Therapeutics 01/2020